ARTICLE | Company News
Sanquin Blood Supply, Synthon deal
March 10, 2017 7:56 PM UTC
Sanquin granted Synthon exclusive, worldwide rights to develop immuno-oncology therapeutics using Sanquin’s antibodies that modulate CD47-signal regulatory protein alpha (SIRPA; CD172a, SHPS-1) intera...
BCIQ Company Profiles